421 related articles for article (PubMed ID: 19395427)
1. Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
Peritogiannis V; Tsouli S
J Psychopharmacol; 2010 Jul; 24(7):1121-5. PubMed ID: 19395427
[TBL] [Abstract][Full Text] [Related]
2. Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report.
Sacchetti E; Valsecchi P
Int Clin Psychopharmacol; 2003 Nov; 18(6):357-9. PubMed ID: 14571157
[TBL] [Abstract][Full Text] [Related]
3. Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: a report of 2 cases.
Gourzis P; Polychronopoulos P; Papapetropoulos S; Assimakopoulos K; Argyriou AA; Beratis S
Clin Neuropharmacol; 2005; 28(4):195-6. PubMed ID: 16062102
[TBL] [Abstract][Full Text] [Related]
4. Tardive dyskinesia rates with atypical antipsychotics in older adults.
Jeste DV
J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
[TBL] [Abstract][Full Text] [Related]
5. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
Margolese HC; Chouinard G; Kolivakis TT; Beauclair L; Miller R; Annable L
Can J Psychiatry; 2005 Oct; 50(11):703-14. PubMed ID: 16363464
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity.
Bressan RA; Jones HM; Pilowsky LS
J Psychopharmacol; 2004 Mar; 18(1):124-7. PubMed ID: 15107196
[TBL] [Abstract][Full Text] [Related]
7. [Utility of quetiapine in tardive dyskinesia].
Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.
Nelson MW; Reynolds RR; Kelly DL; Conley RR
Clin Neuropharmacol; 2003; 26(6):297-8. PubMed ID: 14646608
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia in older patients.
Jeste DV
J Clin Psychiatry; 2000; 61 Suppl 4():27-32. PubMed ID: 10739328
[TBL] [Abstract][Full Text] [Related]
11. Two new atypical antipsychotics: advantages and disadvantages.
Lemon MD
S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
[No Abstract] [Full Text] [Related]
12. Metabolic syndrome in drug-naïve first-episode psychosis treated with atypical antipsychotics.
Sahoo S; Ameen S; Akhtar S
Aust N Z J Psychiatry; 2007 Jul; 41(7):629. PubMed ID: 17691161
[No Abstract] [Full Text] [Related]
13. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 3():16-21. PubMed ID: 10724129
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics for the treatment of disruptive behavior.
Lohr WD; Honaker J
Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
[No Abstract] [Full Text] [Related]
15. Conventional vs. newer antipsychotics in elderly patients.
Jeste DV; Rockwell E; Harris MJ; Lohr JB; Lacro J
Am J Geriatr Psychiatry; 1999; 7(1):70-6. PubMed ID: 9919323
[TBL] [Abstract][Full Text] [Related]
16. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
Ollendorf DA; Joyce AT; Rucker M
MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic drug side effect issues in bipolar manic patients.
Zarate CA
J Clin Psychiatry; 2000; 61 Suppl 8():52-61; discussion 62-3. PubMed ID: 10811244
[TBL] [Abstract][Full Text] [Related]
18. The value of atypical antipsychotics in the treatment of schizophrenia.
Jessen LM
Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
[No Abstract] [Full Text] [Related]
19. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
